Skip to main content
Clinical Trials/CTRI/2019/01/017128
CTRI/2019/01/017128
Recruiting
未知

A Prospective, obseRvational, multicenter study to evaluate safety and efficacy of fix dOse combination of Metformin, glimePiride, and voglibose in Type 2 diabetes mellitus patients

Aprica Healthcare Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Sponsor
Aprica Healthcare Pvt Ltd
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Aprica Healthcare Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients willing to provide written informed consent at the time of enrolment
  • 2\.Male or Female patients above 18 years
  • 3\.Patients suffering from type 2 diabetes mellitus
  • 4\.Patients treated with fixed dose combination metformin, glimepiride and voglibose

Exclusion Criteria

  • 1\.Patients receiving any other antidiabetic agent other than mentioned in inclusion criteria
  • 2\.Patients suffering from any other type of Diabetes except Type 2 diabetes mellitus

Outcomes

Primary Outcomes

Not specified

Similar Trials